The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Molecule CDMO Market Research Report 2025
Synopsis
The global Small Molecule CDMO market was valued at US$ 1162 million in 2023 and is anticipated to reach US$ 2417.3 million by 2030, witnessing a CAGR of 11.5% during the forecast period 2024-2030.
North American market for Small Molecule CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule CDMO in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO.
Report Scope
The Small Molecule CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Segment by Type
Development
API Production
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Small Molecule CDMO market was valued at US$ 1162 million in 2023 and is anticipated to reach US$ 2417.3 million by 2030, witnessing a CAGR of 11.5% during the forecast period 2024-2030.
North American market for Small Molecule CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule CDMO in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO.
Report Scope
The Small Molecule CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Segment by Type
Development
API Production
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Development
1.2.3 API Production
1.3 Market by Application
1.3.1 Global Small Molecule CDMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CDMO Market Perspective (2019-2030)
2.2 Small Molecule CDMO Growth Trends by Region
2.2.1 Global Small Molecule CDMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule CDMO Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule CDMO Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule CDMO Market Dynamics
2.3.1 Small Molecule CDMO Industry Trends
2.3.2 Small Molecule CDMO Market Drivers
2.3.3 Small Molecule CDMO Market Challenges
2.3.4 Small Molecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule CDMO Players by Revenue
3.1.1 Global Top Small Molecule CDMO Players by Revenue (2019-2024)
3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule CDMO Revenue
3.4 Global Small Molecule CDMO Market Concentration Ratio
3.4.1 Global Small Molecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CDMO Revenue in 2023
3.5 Small Molecule CDMO Key Players Head office and Area Served
3.6 Key Players Small Molecule CDMO Product Solution and Service
3.7 Date of Enter into Small Molecule CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CDMO Breakdown Data by Type
4.1 Global Small Molecule CDMO Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule CDMO Forecasted Market Size by Type (2025-2030)
5 Small Molecule CDMO Breakdown Data by Application
5.1 Global Small Molecule CDMO Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule CDMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule CDMO Market Size (2019-2030)
6.2 North America Small Molecule CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Molecule CDMO Market Size by Country (2019-2024)
6.4 North America Small Molecule CDMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule CDMO Market Size (2019-2030)
7.2 Europe Small Molecule CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Molecule CDMO Market Size by Country (2019-2024)
7.4 Europe Small Molecule CDMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule CDMO Market Size (2019-2030)
8.2 Asia-Pacific Small Molecule CDMO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Molecule CDMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Molecule CDMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule CDMO Market Size (2019-2030)
9.2 Latin America Small Molecule CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Molecule CDMO Market Size by Country (2019-2024)
9.4 Latin America Small Molecule CDMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule CDMO Market Size (2019-2030)
10.2 Middle East & Africa Small Molecule CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Molecule CDMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Molecule CDMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule CDMO Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule CDMO Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Detail
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Small Molecule CDMO Introduction
11.3.4 Thermo Fisher Revenue in Small Molecule CDMO Business (2019-2024)
11.3.5 Thermo Fisher Recent Development
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Detail
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CDMO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CDMO Business (2019-2024)
11.4.5 Wuxi Apptec Recent Development
11.5 PharmaBlock
11.5.1 PharmaBlock Company Detail
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CDMO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CDMO Business (2019-2024)
11.5.5 PharmaBlock Recent Development
11.6 Asym Chemical
11.6.1 Asym Chemical Company Detail
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CDMO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CDMO Business (2019-2024)
11.6.5 Asym Chemical Recent Development
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Detail
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2019-2024)
11.7.5 Jiuzhou Pharmaceutical Recent Development
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Detail
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CDMO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CDMO Business (2019-2024)
11.8.5 Pharmaron Beijing Recent Development
11.9 Porton Pharma
11.9.1 Porton Pharma Company Detail
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CDMO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CDMO Business (2019-2024)
11.9.5 Porton Pharma Recent Development
11.10 ChemPartner
11.10.1 ChemPartner Company Detail
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CDMO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CDMO Business (2019-2024)
11.10.5 ChemPartner Recent Development
11.11 Jiangsu Sinopep
11.11.1 Jiangsu Sinopep Company Detail
11.11.2 Jiangsu Sinopep Business Overview
11.11.3 Jiangsu Sinopep Small Molecule CDMO Introduction
11.11.4 Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2019-2024)
11.11.5 Jiangsu Sinopep Recent Development
11.12 DELPHARM
11.12.1 DELPHARM Company Detail
11.12.2 DELPHARM Business Overview
11.12.3 DELPHARM Small Molecule CDMO Introduction
11.12.4 DELPHARM Revenue in Small Molecule CDMO Business (2019-2024)
11.12.5 DELPHARM Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Detail
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Small Molecule CDMO Introduction
11.13.4 Aenova Group Revenue in Small Molecule CDMO Business (2019-2024)
11.13.5 Aenova Group Recent Development
11.14 Siegfried Holding AG
11.14.1 Siegfried Holding AG Company Detail
11.14.2 Siegfried Holding AG Business Overview
11.14.3 Siegfried Holding AG Small Molecule CDMO Introduction
11.14.4 Siegfried Holding AG Revenue in Small Molecule CDMO Business (2019-2024)
11.14.5 Siegfried Holding AG Recent Development
11.15 Recipharm AB
11.15.1 Recipharm AB Company Detail
11.15.2 Recipharm AB Business Overview
11.15.3 Recipharm AB Small Molecule CDMO Introduction
11.15.4 Recipharm AB Revenue in Small Molecule CDMO Business (2019-2024)
11.15.5 Recipharm AB Recent Development
11.16 FAREVA SA
11.16.1 FAREVA SA Company Detail
11.16.2 FAREVA SA Business Overview
11.16.3 FAREVA SA Small Molecule CDMO Introduction
11.16.4 FAREVA SA Revenue in Small Molecule CDMO Business (2019-2024)
11.16.5 FAREVA SA Recent Development
11.17 Almac Group
11.17.1 Almac Group Company Detail
11.17.2 Almac Group Business Overview
11.17.3 Almac Group Small Molecule CDMO Introduction
11.17.4 Almac Group Revenue in Small Molecule CDMO Business (2019-2024)
11.17.5 Almac Group Recent Development
11.18 Cambrex
11.18.1 Cambrex Company Detail
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Small Molecule CDMO Introduction
11.18.4 Cambrex Revenue in Small Molecule CDMO Business (2019-2024)
11.18.5 Cambrex Recent Development
11.19 Charles River
11.19.1 Charles River Company Detail
11.19.2 Charles River Business Overview
11.19.3 Charles River Small Molecule CDMO Introduction
11.19.4 Charles River Revenue in Small Molecule CDMO Business (2019-2024)
11.19.5 Charles River Recent Development
11.20 CORDEN PHARMA
11.20.1 CORDEN PHARMA Company Detail
11.20.2 CORDEN PHARMA Business Overview
11.20.3 CORDEN PHARMA Small Molecule CDMO Introduction
11.20.4 CORDEN PHARMA Revenue in Small Molecule CDMO Business (2019-2024)
11.20.5 CORDEN PHARMA Recent Development
11.21 Jubilant Pharmova
11.21.1 Jubilant Pharmova Company Detail
11.21.2 Jubilant Pharmova Business Overview
11.21.3 Jubilant Pharmova Small Molecule CDMO Introduction
11.21.4 Jubilant Pharmova Revenue in Small Molecule CDMO Business (2019-2024)
11.21.5 Jubilant Pharmova Recent Development
11.22 Consort Medical
11.22.1 Consort Medical Company Detail
11.22.2 Consort Medical Business Overview
11.22.3 Consort Medical Small Molecule CDMO Introduction
11.22.4 Consort Medical Revenue in Small Molecule CDMO Business (2019-2024)
11.22.5 Consort Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Small Molecule CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Development
Table 3. Key Players of API Production
Table 4. Global Small Molecule CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Small Molecule CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Small Molecule CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Small Molecule CDMO Market Share by Region (2019-2024)
Table 8. Global Small Molecule CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Small Molecule CDMO Market Share by Region (2025-2030)
Table 10. Small Molecule CDMO Market Trends
Table 11. Small Molecule CDMO Market Drivers
Table 12. Small Molecule CDMO Market Challenges
Table 13. Small Molecule CDMO Market Restraints
Table 14. Global Small Molecule CDMO Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Small Molecule CDMO Market Share by Players (2019-2024)
Table 16. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2023)
Table 17. Ranking of Global Top Small Molecule CDMO Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Small Molecule CDMO Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Small Molecule CDMO Product Solution and Service
Table 21. Date of Enter into Small Molecule CDMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule CDMO Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Small Molecule CDMO Revenue Market Share by Type (2019-2024)
Table 25. Global Small Molecule CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Small Molecule CDMO Revenue Market Share by Type (2025-2030)
Table 27. Global Small Molecule CDMO Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Small Molecule CDMO Revenue Market Share by Application (2019-2024)
Table 29. Global Small Molecule CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Small Molecule CDMO Revenue Market Share by Application (2025-2030)
Table 31. North America Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Small Molecule CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Small Molecule CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Small Molecule CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Small Molecule CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Small Molecule CDMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Small Molecule CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Small Molecule CDMO Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Small Molecule CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Small Molecule CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Small Molecule CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Small Molecule CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Small Molecule CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 46. Lonza Company Detail
Table 47. Lonza Business Overview
Table 48. Lonza Small Molecule CDMO Product
Table 49. Lonza Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Catalent Company Detail
Table 52. Catalent Business Overview
Table 53. Catalent Small Molecule CDMO Product
Table 54. Catalent Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Thermo Fisher Company Detail
Table 57. Thermo Fisher Business Overview
Table 58. Thermo Fisher Small Molecule CDMO Product
Table 59. Thermo Fisher Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Recent Development
Table 61. Wuxi Apptec Company Detail
Table 62. Wuxi Apptec Business Overview
Table 63. Wuxi Apptec Small Molecule CDMO Product
Table 64. Wuxi Apptec Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 65. Wuxi Apptec Recent Development
Table 66. PharmaBlock Company Detail
Table 67. PharmaBlock Business Overview
Table 68. PharmaBlock Small Molecule CDMO Product
Table 69. PharmaBlock Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 70. PharmaBlock Recent Development
Table 71. Asym Chemical Company Detail
Table 72. Asym Chemical Business Overview
Table 73. Asym Chemical Small Molecule CDMO Product
Table 74. Asym Chemical Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 75. Asym Chemical Recent Development
Table 76. Jiuzhou Pharmaceutical Company Detail
Table 77. Jiuzhou Pharmaceutical Business Overview
Table 78. Jiuzhou Pharmaceutical Small Molecule CDMO Product
Table 79. Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 80. Jiuzhou Pharmaceutical Recent Development
Table 81. Pharmaron Beijing Company Detail
Table 82. Pharmaron Beijing Business Overview
Table 83. Pharmaron Beijing Small Molecule CDMO Product
Table 84. Pharmaron Beijing Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 85. Pharmaron Beijing Recent Development
Table 86. Porton Pharma Company Detail
Table 87. Porton Pharma Business Overview
Table 88. Porton Pharma Small Molecule CDMO Product
Table 89. Porton Pharma Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 90. Porton Pharma Recent Development
Table 91. ChemPartner Company Detail
Table 92. ChemPartner Business Overview
Table 93. ChemPartner Small Molecule CDMO Product
Table 94. ChemPartner Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 95. ChemPartner Recent Development
Table 96. Jiangsu Sinopep Company Detail
Table 97. Jiangsu Sinopep Business Overview
Table 98. Jiangsu Sinopep Small Molecule CDMO Product
Table 99. Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 100. Jiangsu Sinopep Recent Development
Table 101. DELPHARM Company Detail
Table 102. DELPHARM Business Overview
Table 103. DELPHARM Small Molecule CDMO Product
Table 104. DELPHARM Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 105. DELPHARM Recent Development
Table 106. Aenova Group Company Detail
Table 107. Aenova Group Business Overview
Table 108. Aenova Group Small Molecule CDMO Product
Table 109. Aenova Group Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 110. Aenova Group Recent Development
Table 111. Siegfried Holding AG Company Detail
Table 112. Siegfried Holding AG Business Overview
Table 113. Siegfried Holding AG Small Molecule CDMO Product
Table 114. Siegfried Holding AG Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 115. Siegfried Holding AG Recent Development
Table 116. Recipharm AB Company Detail
Table 117. Recipharm AB Business Overview
Table 118. Recipharm AB Small Molecule CDMO Product
Table 119. Recipharm AB Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 120. Recipharm AB Recent Development
Table 121. FAREVA SA Company Detail
Table 122. FAREVA SA Business Overview
Table 123. FAREVA SA Small Molecule CDMO Product
Table 124. FAREVA SA Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 125. FAREVA SA Recent Development
Table 126. Almac Group Company Detail
Table 127. Almac Group Business Overview
Table 128. Almac Group Small Molecule CDMO Product
Table 129. Almac Group Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 130. Almac Group Recent Development
Table 131. Cambrex Company Detail
Table 132. Cambrex Business Overview
Table 133. Cambrex Small Molecule CDMO Product
Table 134. Cambrex Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 135. Cambrex Recent Development
Table 136. Charles River Company Detail
Table 137. Charles River Business Overview
Table 138. Charles River Small Molecule CDMO Product
Table 139. Charles River Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 140. Charles River Recent Development
Table 141. CORDEN PHARMA Company Detail
Table 142. CORDEN PHARMA Business Overview
Table 143. CORDEN PHARMA Small Molecule CDMO Product
Table 144. CORDEN PHARMA Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 145. CORDEN PHARMA Recent Development
Table 146. Jubilant Pharmova Company Detail
Table 147. Jubilant Pharmova Business Overview
Table 148. Jubilant Pharmova Small Molecule CDMO Product
Table 149. Jubilant Pharmova Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 150. Jubilant Pharmova Recent Development
Table 151. Consort Medical Company Detail
Table 152. Consort Medical Business Overview
Table 153. Consort Medical Small Molecule CDMO Product
Table 154. Consort Medical Revenue in Small Molecule CDMO Business (2019-2024) & (US$ Million)
Table 155. Consort Medical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Small Molecule CDMO Market Share by Type: 2023 VS 2030
Figure 3. Development Features
Figure 4. API Production Features
Figure 5. Global Small Molecule CDMO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Small Molecule CDMO Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Case Studies
Figure 8. Biotechnology Case Studies
Figure 9. Small Molecule CDMO Report Years Considered
Figure 10. Global Small Molecule CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Small Molecule CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Small Molecule CDMO Market Share by Region: 2023 VS 2030
Figure 13. Global Small Molecule CDMO Market Share by Players in 2023
Figure 14. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Small Molecule CDMO Revenue in 2023
Figure 16. North America Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Small Molecule CDMO Market Share by Country (2019-2030)
Figure 18. United States Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Small Molecule CDMO Market Share by Country (2019-2030)
Figure 22. Germany Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Small Molecule CDMO Market Share by Region (2019-2030)
Figure 30. China Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Small Molecule CDMO Market Share by Country (2019-2030)
Figure 38. Mexico Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule CDMO Market Share by Country (2019-2030)
Figure 42. Turkey Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Small Molecule CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Lonza Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 45. Catalent Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 46. Thermo Fisher Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 47. Wuxi Apptec Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 48. PharmaBlock Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 49. Asym Chemical Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 50. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 51. Pharmaron Beijing Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 52. Porton Pharma Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 53. ChemPartner Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 54. Jiangsu Sinopep Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 55. DELPHARM Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 56. Aenova Group Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 57. Siegfried Holding AG Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 58. Recipharm AB Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 59. FAREVA SA Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 60. Almac Group Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 61. Cambrex Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 62. Charles River Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 63. CORDEN PHARMA Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 64. Jubilant Pharmova Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 65. Consort Medical Revenue Growth Rate in Small Molecule CDMO Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
